Weight Loss

BOTOX^®

Jump-start your weight-loss journey with medical‑grade support using GLP‑1 medications—semaglutide and tirzepatide—offered in both microdosing and full-dose programs tailored to your goals.

Savings without Compromise

Educational Experience Guaranteed

Book Now

Schedule Consultation

Rapid Initial Results: Expect ~5% average weight loss in the first month.
Long-Term Effectiveness: Up to 15% total weight loss over six months, with improved results after month three.
Evidence-Based Medications: Supported by clinical trials showing substantial reductions in body weight.

Monthly Program: Semaglutide at $400/month or tirzepatide at $500/month—includes initial injection, guided self‑injection training, and a 4‑week follow‑up.
6‑Month Comprehensive Option: Semaglutide for $3,900 or tirzepatide for $4,600—add B‑12/lipolean injections weekly, monthly signature IVs, 10% off aesthetic services, and continued follow‑up.
Optional micro‑dosing available for gradual titration.

Pre-Treatment:
- Complimentary consultation with medical history review.
- Ensure BMI ≥27 with comorbidities or ≥30 for eligibility.
During Treatment:
1. Initial injection with self-injection instruction.
2. Continued weekly at-home dosing—Semaglutide ($400/month) or Tirzepatide ($500/month).
3. Follow-up at 4 weeks; ongoing monthly check-ins for 6-month plan with B‑12/Lipolean injections and IV therapy.
4. Memberships also receive 10% off products and aesthetic services.
Post-Treatment:
- Monitor side effects and weight.
- Adjust dosage as needed.
- Emphasize nutrition, exercise, resistance training to preserve lean mass.
- Plan continued check-ups if discontinuing post–initial visit (otherwise, a $199 consult fee applies).

GLP‑1 agonists like semaglutide (Wegovy®) and tirzepatide (Zepbound®/Mounjaro®) mimic gut hormones that regulate appetite and satiety.

Semaglutide reduces hunger and slows stomach emptying, with weekly doses up to 2.4 mg.
Tirzepatide adds dual GIP/GLP‑1 action, leading to even greater weight loss—up to 20% in trials.

Monthly or 6‑month programs include consultation, medical review, injection training, and progress monitoring. Long-term success depends on continuing therapy and maintaining lifestyle changes.

How do semaglutide and tirzepatide work?

They mimic gut hormones (GLP‑1 for semaglutide; GLP‑1 + GIP for tirzepatide), reducing appetite, slowing digestion, and promoting satiety for effective weight reductions.

How much weight can I expect to lose?

Semaglutide users averaged ~15% weight loss; tirzepatide users saw ~20% in trials, with initial loss around 5% in month one.

What is the dosing schedule?

Semaglutide starts at 0.25 mg weekly, titrating up to 2.4 mg by month 4–5 .

Tirzepatide begins at 2.5 mg weekly, increasing by 2.5 mg increments every 4 weeks to a maintenance dose of 5–15 m.

Are there side effects?

Gastrointestinal symptoms (nausea, diarrhea, constipation) are common, but usually decrease over time. Titration helps minimize these issues.

How long will I need treatment?

Continuing therapy is crucial—stopping often reverses weight loss. In long-term studies, stopping tirzepatide led to weight regain, while ongoing use maintained benefits.